Dabigatran etexilate Enrolling by Invitation Phase 4 Trials for Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02646267The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients